# Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients

> **NCT00521885** · NA · TERMINATED · sponsor: **Lehigh Valley Hospital** · enrollment: 1 (actual)

## Conditions studied

- Venous Thrombosis

## Interventions

- **DRUG:** Arixtra (Fondaparinox) 2.5 mg SC Daily
- **DRUG:** Lovenox 40mg SC Daily

## Key facts

- **NCT ID:** NCT00521885
- **Lead sponsor:** Lehigh Valley Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-09
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study stopped due to lack of accrual
- **Last updated:** 2021-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00521885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00521885, "Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00521885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*